Choose Your Language:
Posted by: The Sumaira Foundation in NMO, Patient, Voices of NMO
It all began in June 2020, the peak of when COVID-19 had finally hit Texas… Allow me to backtrack before I began with my symptoms for a bit: I have […]
Read MorePosted by: The Sumaira Foundation in NMO, Patient, Voices of NMO
On January 30, 2023, I was diagnosed with relapsing-remitting multiple sclerosis following the onset of nearly complete vision loss in my left eye. That day marked a profound turning point […]
Read MorePosted by: The Sumaira Foundation in News & Announcements
March 7, 2024 — The Sumaira Foundation (TSF) is delighted to announce a new partnership during NMO and MS Awareness Months with We Are ILL, a nonprofit patient advocacy organization […]
Read MorePosted by: The Sumaira Foundation in
Posted by: The Sumaira Foundation in
Posted by: The Sumaira Foundation in NMO, Patient, Voices of NMO
Nel mese di marzo 2012 avevo appena trovato lavoro a più di 60 chilometri da casa ma era il lavoro per il quale avevo appena terminato gli studi ed ero […]
Read MorePosted by: The Sumaira Foundation in
Neem vrijdag 17 maart van 20.00-21.00 uur deel aan het allereerste Nederlandstalige webinar “In gesprek met deskundigen” (“From the Experts”). Dit webinar wordt georganiseerd door de Sumaira Foundation. Dr Barbara […]
Read MorePosted by: The Sumaira Foundation in NMO, Patient, Voices of NMO
Els is ambassadeur voor de Sumaira Foundation, die opkomt voor de belangen van mensen met NMOSD en MOGAD. Zelf kreeg ze begin 2022 de diagnose van NMOSD. Ik werd in […]
Read MorePosted by: The Sumaira Foundation in
Herzliche Einladung zum ersten Live-Webinar “NMOSD, MOGAD und MS: Gemeinsamkeiten und Unterschiede” der Sumaira-Foundation für die deutschsprachige NMOSD & MOGAD Community am Montag, den 13. Februar, mit Dr. Joachim Havla, […]
Read MorePosted by: The Sumaira Foundation in
There are a number of different autoimmune disorders with similar features to Multiple Sclerosis (MS), such as neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disorder (MOGAD). These […]
Read More
